Image de couverture de livre

Should male children be vaccinated against human papillomavirus?

Fuente: Redalyc

Enregistré dans:

Détails bibliographiques
Auteur principal:	Gerardo Sebastián Legua-Pérez
Format:	Artículo científico
Langue:	en
Publié:	Universidad Nacional de Colombia 2017
Sujets:	Medicina
Accès en ligne:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

ARTRITIS PSORIASICA MUTILANTE EN MIEMBRO INFERIOR
par: Sebastian Legua-Perez
Publié: (2017)

Knowledge and attitudes of Mexican mothers in the non-acceptance of the human papillomavirus vaccine
par: Gabriela Iveth Martínez-Figueroa
Publié: (2023)

Cost‐effectiveness of risk‐stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage
par: Tiago M. de Carvalho, et autres
Publié: (2026)

Extending vaccination periods against human papillomavirus: Lessons from the SARS‐CoV‐2 pandemic
par: Juliette Calvez, et autres
Publié: (2024)

The AOFOG recommendations on human papillomavirus vaccination in the Asia‐Pacific region
par: Ka Yu Tse, et autres
Publié: (2024)

Letter to the editor in response to the article “Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China”
par: Xueying Liu
Publié: (2024)

Human papillomavirus (HPV) vaccination in Japan
par: Etsuko Miyagi
Publié: (2024)

Missed opportunities for human papillomavirus vaccination using Iowa's Immunization Registry Information System
par: Ona R. Loper, et autres
Publié: (2024)

Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
par: Mònica Ortega Llobet, et autres
Publié: (2025)

Human papillomavirus‐related cancers and human papillomavirus vaccination among Arab Americans: A call to unveil disparities and bridge the research gaps
par: Nada Al‐Antary, et autres
Publié: (2025)

Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer
par: Alejandro García
Publié: (2003)

Examining dental providers counseling on human papillomavirus vaccine: Insights from parents and dental professionals
par: Luis Barrientos, et autres
Publié: (2024)

Serology for human papillomavirus
par: Pierre Coursaget
Publié: (2003)

Cost‐effectiveness analysis of 9‐valent human papillomavirus vaccine combined with screening for cervical cancer in Japan
par: Naohiro Takamoto, et autres
Publié: (2024)

Lack of knowledge about the human papillomavirus vaccine among Brazilian adolescents: A cross‐sectional study
par: Tércia Moreira Ribeiro da Silva, et autres
Publié: (2024)

Estimation of self‐funded human papillomavirus vaccine recipients from Japan's previously assumed “unvaccinated generation”
par: Mariya Kobayashi, et autres
Publié: (2024)

The effect of the vaccine on the severity of infection on children with mumps
par: Venus Hassan Abdul Amir
Publié: (2021)

Molecular detection of oncogenic subtypes of human papillomavirus (HPV) in a group of women in the Amazon region of Brazil
par: Alessandra Silva e Silva
Publié: (2020)

Vaccine against human Papilloma Virus
par: Julio C Reina
Publié: (2014)

Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process
par: Minsoo Kim, et autres
Publié: (2024)

Reply to: combined systemic and intralesional 9‐valent human papillomavirus vaccine for recurrent squamous cell carcinoma in situ of the penis
par: Georgios Kravvas, et autres
Publié: (2024)

Safety and immunogenicity of vaccines against SARS-CoV-2
par: Francisco Xavier Poveda Paredes
Publié: (2021)

Investigating the association of chemokine receptor 5 (CCR5) polymorphism with cervical cancer in human papillomavirus (HPV) positive patients
par: Patrícia Sayuri Suzuki
Publié: (2008)

Netherton syndrome and papillomatous lesions—Should we perform human papilloma virus vaccination?
par: Regina Fölster‐Holst, et autres
Publié: (2024)

Educational intervention on the human papillomavirus and quality of information
par: Ramón Álvarez López
Publié: (2025)

Comparison of Hybribio-H13 and Hybrid Capture® 2 human papillomavirus tests for detection of CIN2+ and CIN3+
par: María Cecilia Agudelo
Publié: (2024)

Interaction between the level of human papillomavirus integration and human papillomavirus type on the risk of grade 3 cervical intraepithelial neoplasia or more severe in human papillomavirus integration positive women: A cross‐sectional study
par: Xin Liu, et autres
Publié: (2025)

Validation of a triple‐color pseudovirion‐based neutralization assay for immunogenicity assessment of a 14‐valent recombinant human papillomavirus vaccine
par: Shuman Gao, et autres
Publié: (2024)

Causes of delayed immunization with pneumococcal vaccine and aetiological patterns of pneumonia in young children
par: Abolfazl Gholamrezaei
Publié: (2019)

Barriers in the prevention and early detection of human papillomavirus in Latin America
par: Leopoldo Santiago Sanabria, et autres
Publié: (2025)

Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia
par: Carlos Reina
Publié: (2021)

Molecular diagnosis of human papillomavirus in the development of cervical cancer
par: Lourdes Gutiérrez-Xicoténcatl
Publié: (2009)

Message framing's limited efficacy in counteracting parental hesitancy towards human papillomavirus vaccination for female adolescents: Insights from a randomized trial
par: Naiyang Shi, et autres
Publié: (2024)

Resolution of extensive plantar verruca vulgaris but not facial verruca plana following nonavalent human papillomavirus vaccine: A case report and literature review
par: Kyung Ho Lee, et autres
Publié: (2024)

Impact of human papillomavirus types on uterine cervical neoplasia
par: Ayumi Taguchi, et autres
Publié: (2024)

Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis
par: Romina A Tejada
Publié: (2017)

Pharmacists and the reluctance to vaccines
par: Antoni Trilla
Publié: (2019)

Human papillomavirus and other risk factors in Lithuanian cervical carcinoma patients
par: Živilė Gudlevičienė
Publié: (2010)

Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension
par: Mariana Nogueira de Paula Rosa
Publié: (2008)

Knowledge, acceptance, uptake barriers and missed opportunities of human papillomavirus vaccine among female adolescents in Benin City, Nigeria: A mixed method study
par: Ese‐Ose Obehi‐Oye Imarengiaye, et autres
Publié: (2025)